benzoxazoles has been researched along with Diabetic Neuropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebert, P; Fijal, B; Grubisha, O; Langron, E; McNearney, TA; Merchant, K; Mogg, A; Munsie, L; Qian, YW; Ruble, C; Sher, E; Ursu, D; Zou, W | 1 |
| Gaus, S; Kajiyama, S; Kawamoto, M; Matsunaga, A; Shiraishi, S; Suyama, H; Yuge, O | 1 |
2 other study(ies) available for benzoxazoles and Diabetic Neuropathies
| Article | Year |
|---|---|
Gain and loss of function of P2X7 receptors: mechanisms, pharmacology and relevance to diabetic neuropathic pain.
Topics: Adenosine Triphosphate; Analysis of Variance; Benzoxazoles; Calcium; Diabetic Neuropathies; Female; Gene Expression Regulation; Genotype; HEK293 Cells; Humans; Male; Middle Aged; Pain Measurement; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Purinergic P2X Receptor Antagonists; Quinolinium Compounds; Receptors, Purinergic P2X7; Transfection | 2014 |
Spinal orexin-1 receptors mediate anti-hyperalgesic effects of intrathecally-administered orexins in diabetic neuropathic pain model rats.
Topics: Animals; Behavior, Animal; Benzoxazoles; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Drug Interactions; Hyperalgesia; Injections, Spinal; Intracellular Signaling Peptides and Proteins; Male; Naloxone; Naphthyridines; Narcotic Antagonists; Neuropeptides; Orexin Receptors; Orexins; Pain Measurement; Pain Threshold; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Spinal Cord; Streptozocin; Time Factors; Urea | 2005 |